Key result
This document is a journal masthead and contains no clinical study data.
Why the study?
What are the strengths and weaknesses of dabigatran compared to warfarin in terms of pharmacokinetics and clinical data?
Comparison
Dabigatran (oral thrombin inhibitor) vs Warfarin
Design
Review
Authors
Loading...
No clinical data available; leaves open dabigatran's pharmacokinetic and clinical advantages over warfarin.
What are the strengths and weaknesses of dabigatran compared to warfarin in terms of pharmacokinetics and clinical data?
This review highlights that while dabigatran is not a perfect anticoagulant, its pharmacokinetic and clinical profile makes it superior to warfarin in many aspects.
Schulman et al. (2012) studied this question. This document is a journal masthead and contains no clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: